Feng Zhang

Feng Zhang
Feng Zhang
张锋
	Zhang in 2017
Born	October 22, 1981 (age 42); Shijiazhuang, Hebei, China
Nationality	American
Education	Harvard University (BA); Stanford University (PhD);
Known for	Optogenetics, CRISPR
Awards	Edward Novitski Prize (2021); Harvey Prize (2018); Keio Medical Science Prize (2018); National Academy of Sciences (2018); American Academy of Arts & Sciences (2018); Lemelson-MIT Prize (2017); Albany Medical Center Prize (2017); Gairdner Foundation International Award (2016); Tang Prize (2016); Tsuneko & Reiji Okazaki Award (2015); Alan T. Waterman Award (2014); Gabbay Award (2014); NIH Director’s Pioneer Award (2012); Perl-UNC Prize (2011);
	Scientific career
Fields	Neuroscience; Bioengineering
Institutions	Massachusetts Institute of Technology; Broad Institute
Thesis	Circuit-breakers: optical technologies for probing neural signals and systems (2009)
Doctoral advisor	Karl Deisseroth
Other academic advisors	Paola Arlotta, George Church
Doctoral students	Silvana Konermann
Website	zlab.mit.edu

Feng Zhang (Chinese: 张锋; pinyin: Zhāng Fēng; born October 22, 1981) is a Chinese–American biochemist. Zhang currently holds the James and Patricia Poitras Professorship in Neuroscience at the McGovern Institute for Brain Research and in the departments of Brain and Cognitive Sciences and Biological Engineering at the Massachusetts Institute of Technology. He also has appointments with the Broad Institute of MIT and Harvard (where he is a core member). He is most well known for his central role in the development of optogenetics and CRISPR technologies.